The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 08, 2021

Filed:

Nov. 14, 2017
Applicants:

Max-delbrück-centrum Für Molekulare Medizin IN Der Helmholtz-gemeinschaft, Berlin, DE;

Forschungsverbund Berlin E.v., Berlin, DE;

Inventors:

Claus Scheidereit, Berlin, DE;

Michael Willenbrock, Berlin, DE;

Peter Lindemann, Berlin, DE;

Silke Radetzki, Berlin, DE;

Jens-Peter Von Kries, Panketal, DE;

Marc Nazare, Berlin, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); A61P 35/00 (2006.01); C07D 209/56 (2006.01); C07D 221/06 (2006.01); C07D 471/14 (2006.01); C07D 487/04 (2006.01); C07D 471/16 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61P 35/00 (2018.01); C07D 209/56 (2013.01); C07D 221/06 (2013.01); C07D 471/14 (2013.01); C07D 471/16 (2013.01); C07D 487/04 (2013.01);
Abstract

A method is for treatment of a disease associated with genotoxic stress-induced inhibitor of nuclear factor-κB kinase/nuclear factor kappa-light chain enhancer of activated B cells (IKK/NF-κB) signaling. The method can include administering a compound to a subject having a cancer exhibiting genotoxic stress induced IKK/NF-κB activation.


Find Patent Forward Citations

Loading…